Douglas A Treco Inozyme Pharma, Inc. (INZY) insider trading activity

INZY Quotes by TradingView

Douglas A Treco is CEO of Inozyme Pharma, Inc.. Currently has a direct ownership of 22,375 shares of INZY, which is worth approximately $62,873. The most recent transaction as insider was on Sep 30, 2024, when has been sold 1,710 shares (Common Stock) at a price of $4.45 per share, resulting in proceeds of $7,609. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.4K
8.27% 3M change
n/a 12M change
Total Value Held $62,873

Douglas A Treco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2024
BUY
Grant, award, or other acquisition
$7,609 $4.45 p/Share
1,710 Added 7.1%
22,375 Common Stock
Apr 02 2024
SELL
Open market or private sale
$52,209 $6.94 p/Share
7,523 Reduced 26.69%
20,665 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
-
25,000 Added 47.0%
28,188 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
DAT

Douglas A Treco

CEO
Cambridge, MA

Track Institutional and Insider Activities on INZY

Follow Inozyme Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INZY shares.

Notify only if

Insider Trading

Get notified when an Inozyme Pharma, Inc. insider buys or sells INZY shares.

Notify only if

News

Receive news related to Inozyme Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INZY